2662291
SCDGP · Clinical drug group packinfluenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Product
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Product?
influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Product is coded as 2662291 in RxNorm.
What is RxNorm code 2662291?
2662291 is the RxNorm identifier for influenza A virus A/Tasmania/503/2020 (H3N2) antigen / influenza A virus A/Washington/19/2020 (H1N1) antigen / influenza B virus B/Darwin/7/2019 antigen / influenza B virus B/Singapore/INFTT-16-0610/2016 antigen Injectable Product. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2662291?
2662291 is a SCDGP (Clinical drug group pack) in RxNorm.
What is the UMLS mapping for 2662291?
2662291 maps to UMLS C5846095.